Related Experiment Video

Updated: Jun 14, 2026

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs
08:58

Development of a Neonatal Piglet Acute Lung Injury Model Recreating the Early Environment of Preterm Infant Lungs

Published on: October 31, 2025

More than baby steps: perspectives on pediatric translational research

Edward Connor1, Donald Lombardi, John van den Anker

  • 1Children's National Medical Center, Washington, DC 20010, USA. econnor@cnmc.org

Science Translational Medicine
|April 7, 2010
PubMed

Insights

Pediatric product development often lags adult development, despite children comprising a significant population. Addressing challenges in pediatric research is crucial for advancing child health through clinical and translational medicine.

Area of Science:

  • Pediatric Health
  • Clinical and Translational Medicine
  • Medical Product Development

Background:

  • Children constitute a substantial portion of the global population (nearly 40%) and the U.S. population (25%).
  • Pediatric product development historically receives less attention and investment compared to adult-targeted products.
  • Unique challenges and considerations are inherent in pediatric research and development.

Purpose of the Study:

  • To outline the key challenges and opportunities in pediatric product development.
  • To highlight the specific issues encountered in conducting pediatric research.
  • To emphasize the importance of advancing pediatric health.

Main Methods:

  • This study provides a descriptive overview of the landscape of pediatric product development.
  • It synthesizes existing knowledge on the barriers and facilitators in pediatric research.
  • The authors discuss strategic approaches to improve pediatric product innovation.

Main Results:

  • Pediatric product development faces significant hurdles, including regulatory complexities, smaller market sizes, and ethical considerations.
  • Opportunities exist to leverage advancements in translational medicine to accelerate the development of needed pediatric therapies and products.
  • Effective pediatric research requires tailored methodologies and dedicated resources.

Conclusions:

  • Advancing pediatric health is a critical priority requiring focused investment and strategic planning.
  • Overcoming the challenges in pediatric product development is essential for ensuring equitable health outcomes for children.
  • Continued innovation in clinical and translational medicine is vital for the future of pediatric healthcare.

More Related Videos

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy09:57

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy

Published on: September 20, 2024

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Improving Translational Accuracy02:07

Improving Translational Accuracy

Base complementarity between the three base pairs of mRNA codon and the tRNA anticodon is not a failsafe mechanism. Inaccuracies can range from a single mismatch to no correct base pairing at all. The free energy difference between the correct and nearly correct base pairs can be as small as 3 kcal/ mol. With complementarity being the only proofreading step, the estimated error frequency would be one wrong amino acid in every 100 amino acids incorporated. However, error frequencies observed in...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...